Logo image of ERO.CA

ERO COPPER CORP (ERO.CA) Stock Fundamental Analysis

TSX:ERO - Toronto Stock Exchange - CA2960061091 - Common Stock - Currency: CAD

18.18  -1.08 (-5.61%)

Fundamental Rating

6

ERO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 818 industry peers in the Metals & Mining industry. ERO scores excellent on profitability, but there are concerns on its financial health. ERO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ERO had positive earnings in the past year.
ERO had a positive operating cash flow in the past year.
Each year in the past 5 years ERO has been profitable.
Each year in the past 5 years ERO had a positive operating cash flow.
ERO.CA Yearly Net Income VS EBIT VS OCF VS FCFERO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

ERO has a Return On Assets of 1.13%. This is amongst the best in the industry. ERO outperforms 86.89% of its industry peers.
ERO has a better Return On Equity (2.39%) than 87.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.49%, ERO belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
ERO had an Average Return On Invested Capital over the past 3 years of 18.58%. This is significantly above the industry average of 11.82%.
The last Return On Invested Capital (6.49%) for ERO is well below the 3 year average (18.58%), which needs to be investigated, but indicates that ERO had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.13%
ROE 2.39%
ROIC 6.49%
ROA(3y)14.62%
ROA(5y)14.82%
ROE(3y)27.2%
ROE(5y)30.44%
ROIC(3y)18.58%
ROIC(5y)20.71%
ERO.CA Yearly ROA, ROE, ROICERO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

ERO's Profit Margin of 3.67% is amongst the best of the industry. ERO outperforms 90.95% of its industry peers.
ERO's Profit Margin has improved in the last couple of years.
ERO has a Operating Margin of 22.40%. This is amongst the best in the industry. ERO outperforms 94.05% of its industry peers.
In the last couple of years the Operating Margin of ERO has remained more or less at the same level.
ERO's Gross Margin of 36.63% is amongst the best of the industry. ERO outperforms 93.38% of its industry peers.
In the last couple of years the Gross Margin of ERO has remained more or less at the same level.
Industry RankSector Rank
OM 22.4%
PM (TTM) 3.67%
GM 36.63%
OM growth 3Y-21.83%
OM growth 5Y0.75%
PM growth 3Y10.89%
PM growth 5YN/A
GM growth 3Y-14.17%
GM growth 5Y0.8%
ERO.CA Yearly Profit, Operating, Gross MarginsERO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ERO is creating value.
ERO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ERO has more shares outstanding
ERO has a better debt/assets ratio than last year.
ERO.CA Yearly Shares OutstandingERO.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ERO.CA Yearly Total Debt VS Total AssetsERO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

ERO has an Altman-Z score of 1.97. This is not the best score and indicates that ERO is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.97, ERO perfoms like the industry average, outperforming 53.24% of the companies in the same industry.
ERO has a Debt/Equity ratio of 0.71. This is a neutral value indicating ERO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, ERO is doing worse than 81.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.68
WACC9.61%
ERO.CA Yearly LT Debt VS Equity VS FCFERO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

2.3 Liquidity

ERO has a Current Ratio of 0.68. This is a bad value and indicates that ERO is not financially healthy enough and could expect problems in meeting its short term obligations.
ERO has a worse Current ratio (0.68) than 70.41% of its industry peers.
A Quick Ratio of 0.42 indicates that ERO may have some problems paying its short term obligations.
ERO's Quick ratio of 0.42 is on the low side compared to the rest of the industry. ERO is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.42
ERO.CA Yearly Current Assets VS Current LiabilitesERO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

7

3. Growth

3.1 Past

ERO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.89%.
Measured over the past years, ERO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.38% on average per year.
ERO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.51%.
The Revenue has been growing by 12.89% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.89%
EPS 3Y-11.38%
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y9.67%
Revenue growth 5Y12.89%
Sales Q2Q%18.67%

3.2 Future

Based on estimates for the next years, ERO will show a very strong growth in Earnings Per Share. The EPS will grow by 43.41% on average per year.
The Revenue is expected to grow by 20.38% on average over the next years. This is a very strong growth
EPS Next Y6.17%
EPS Next 2Y62.73%
EPS Next 3Y49.56%
EPS Next 5Y43.41%
Revenue Next Year12.58%
Revenue Next 2Y40.66%
Revenue Next 3Y31.08%
Revenue Next 5Y20.38%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERO.CA Yearly Revenue VS EstimatesERO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ERO.CA Yearly EPS VS EstimatesERO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.67 indicates a correct valuation of ERO.
Based on the Price/Earnings ratio, ERO is valued cheaply inside the industry as 91.35% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ERO to the average of the S&P500 Index (29.62), we can say ERO is valued slightly cheaper.
A Price/Forward Earnings ratio of 5.56 indicates a rather cheap valuation of ERO.
ERO's Price/Forward Earnings ratio is rather cheap when compared to the industry. ERO is cheaper than 96.22% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ERO to the average of the S&P500 Index (22.70), we can say ERO is valued rather cheaply.
Industry RankSector Rank
PE 15.67
Fwd PE 5.56
ERO.CA Price Earnings VS Forward Price EarningsERO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

91.76% of the companies in the same industry are more expensive than ERO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.51
ERO.CA Per share dataERO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ERO may justify a higher PE ratio.
A more expensive valuation may be justified as ERO's earnings are expected to grow with 49.56% in the coming years.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y62.73%
EPS Next 3Y49.56%

0

5. Dividend

5.1 Amount

No dividends for ERO!.
Industry RankSector Rank
Dividend Yield N/A

ERO COPPER CORP

TSX:ERO (2/21/2025, 7:00:00 PM)

18.18

-1.08 (-5.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)03-06 2025-03-06/amc
Inst Owners73.35%
Inst Owner ChangeN/A
Ins Owners7.7%
Ins Owner ChangeN/A
Market Cap1.88B
Analysts81.25
Price Target27.96 (53.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.26%
Min EPS beat(2)-17.83%
Max EPS beat(2)11.31%
EPS beat(4)2
Avg EPS beat(4)7.17%
Min EPS beat(4)-18.14%
Max EPS beat(4)53.36%
EPS beat(8)3
Avg EPS beat(8)0.77%
EPS beat(12)4
Avg EPS beat(12)-10.21%
EPS beat(16)6
Avg EPS beat(16)-6.54%
Revenue beat(2)0
Avg Revenue beat(2)-12.01%
Min Revenue beat(2)-20.39%
Max Revenue beat(2)-3.62%
Revenue beat(4)1
Avg Revenue beat(4)-6.69%
Min Revenue beat(4)-20.39%
Max Revenue beat(4)4.83%
Revenue beat(8)3
Avg Revenue beat(8)-4.78%
Revenue beat(12)4
Avg Revenue beat(12)-5.94%
Revenue beat(16)7
Avg Revenue beat(16)-1.8%
PT rev (1m)-14.72%
PT rev (3m)-18.33%
EPS NQ rev (1m)-10.57%
EPS NQ rev (3m)-10.57%
EPS NY rev (1m)-22.94%
EPS NY rev (3m)-31.42%
Revenue NQ rev (1m)-14.2%
Revenue NQ rev (3m)-14.04%
Revenue NY rev (1m)-8.56%
Revenue NY rev (3m)-20.76%
Valuation
Industry RankSector Rank
PE 15.67
Fwd PE 5.56
P/S 2.86
P/FCF N/A
P/OCF 9.9
P/B 1.86
P/tB 1.86
EV/EBITDA 9.51
EPS(TTM)1.16
EY6.38%
EPS(NY)3.27
Fwd EY17.99%
FCF(TTM)-3.47
FCFYN/A
OCF(TTM)1.84
OCFY10.11%
SpS6.36
BVpS9.76
TBVpS9.76
PEG (NY)2.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.13%
ROE 2.39%
ROCE 7.85%
ROIC 6.49%
ROICexc 6.59%
ROICexgc 6.59%
OM 22.4%
PM (TTM) 3.67%
GM 36.63%
FCFM N/A
ROA(3y)14.62%
ROA(5y)14.82%
ROE(3y)27.2%
ROE(5y)30.44%
ROIC(3y)18.58%
ROIC(5y)20.71%
ROICexc(3y)24.15%
ROICexc(5y)25.38%
ROICexgc(3y)24.15%
ROICexgc(5y)25.38%
ROCE(3y)22.45%
ROCE(5y)25.03%
ROICexcg growth 3Y-43.94%
ROICexcg growth 5Y-15.27%
ROICexc growth 3Y-43.94%
ROICexc growth 5Y-15.27%
OM growth 3Y-21.83%
OM growth 5Y0.75%
PM growth 3Y10.89%
PM growth 5YN/A
GM growth 3Y-14.17%
GM growth 5Y0.8%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 2.59
Cap/Depr 419.97%
Cap/Sales 83.36%
Interest Coverage 3.48
Cash Conversion 68.35%
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.42
Altman-Z 1.97
F-Score3
WACC9.61%
ROIC/WACC0.68
Cap/Depr(3y)480.33%
Cap/Depr(5y)394.17%
Cap/Sales(3y)71.42%
Cap/Sales(5y)57.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.89%
EPS 3Y-11.38%
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y6.17%
EPS Next 2Y62.73%
EPS Next 3Y49.56%
EPS Next 5Y43.41%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y9.67%
Revenue growth 5Y12.89%
Sales Q2Q%18.67%
Revenue Next Year12.58%
Revenue Next 2Y40.66%
Revenue Next 3Y31.08%
Revenue Next 5Y20.38%
EBIT growth 1Y3.42%
EBIT growth 3Y-14.27%
EBIT growth 5Y13.74%
EBIT Next Year150.51%
EBIT Next 3Y88.05%
EBIT Next 5Y49.63%
FCF growth 1Y-180.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.88%
OCF growth 3Y0.06%
OCF growth 5Y14.49%